IBO

Conviction 30HealthcareScan · Thu, Jun 25, 2026

Three outside down

IBO$0.4761-4.34%

ResistanceSupportVol 14

Vol MA14 105.96K

Mar 26Apr 14May 1May 19Jun 8Jun 25

IMPACT BIOMEDICAL INC.PHARMACEUTICAL PREPARATIONSwww.impactbiomedinc.com ↗

Price0.4761

Change-4.34%

Gap-1.45%

Rel volume2.31×

Avg volume89.43K

Avg $ vol48.32K

SMA 200.5427

SMA 500.5856

SMA 2000.5512

Price vs 50-18.70%

Price vs 200-13.62%

MA stackmixed

50/200 cross—

Supertrenddown · 0.6109

RSI (14)38

MACD hist-0.01

MACD crossbear · 1d

Stoch %K / %D15 / 17

ADX (14)14

+DI / −DI13 / 27

RSI divergence—

MACD divergenceBullish

ATR %+9.80%

ADR %7.81%

52w high0.9618

52w low0.4008

From 52w high-50.50%

Above 52w low+18.79%

New 52w highNo

SqueezeOn · 12d

Bollinger width21.32%

%B-0.08

Donchian pos15.35%

Donchian high0.6200

Donchian low0.4500

AVWAP (52w high)0.6521

vs AVWAP high-26.99%

AVWAP (52w low)0.6328

vs AVWAP low-24.76%

OBV trendFlat

Chaikin MF (20)0.07

Today vs 20d2.31×

Avg vol (14d)105.96K

Avg vol (20d)89.43K

Avg $ vol (20d)48.32K

Market cap51.33M

RS 3m (vs SPY)-31.98%

RS 6m (vs SPY)-31.06%

RS line new highNo

Trend template0/8

Technical rank19.7

1 week-17.49%

1 month-7.01%

3 months-18.31%

6 months-14.68%

1 year-43.32%

YTD-8.18%

P/E-4.34

P/B4.48

P/S—

P/FCF—

EPS-0.3800

Div yield—

ROE-103.26%

ROA-69.28%

Debt/Eq1.04

Current0.22

EV/EBITDA-20.15

Gross margin—

Net margin—

Rev growth-36.00%

EPS growth52.09%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value63.21M

Revenue7K

Net income-2.29M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNYSE

Shares out107.82M

Employees8

ListedMon, Sep 16, 2024

Free float1.32M

Float %10.9%

Short interest750.05K

Days to cover21.7d

Short volume14.5%

Squeeze score80 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeD

Conviction30 / 100

Pattern quality—

Tech rank19.7 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmThree outside down

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in IBO

All disclosures →

No recent disclosed trades by Congress in IBO. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in IBO

No recent insider (Form 4) filings in IBO. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in IBO

EDGAR →

No recent SEC filings on file for IBO.

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.